Ameriprise’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.9M | Buy |
1,815,930
+298,759
| +20% | +$1.68M | ﹤0.01% | 1932 |
|
|
2025
Q4 | $10.6M | Sell |
1,517,171
-767,526
| -34% | -$6.01M | ﹤0.01% | 1866 |
|
|
2025
Q3 | $17.7M | Buy |
2,284,697
+227,385
| +11% | +$1.77M | ﹤0.01% | 1495 |
|
|
2025
Q2 | $17.9M | Sell |
2,057,312
-164,324
| -7% | -$1.19M | ﹤0.01% | 1426 |
|
|
2025
Q1 | $17.7M | Buy |
2,221,636
+915,776
| +70% | +$9.26M | ﹤0.01% | 1388 |
|
|
2024
Q4 | $11.9M | Sell |
1,305,860
-218,119
| -14% | -$2.11M | ﹤0.01% | 1670 |
|
|
2024
Q3 | $14M | Buy |
1,523,979
+347,708
| +30% | +$2.88M | ﹤0.01% | 1539 |
|
|
2024
Q2 | $11.5M | Buy |
1,176,271
+413,064
| +54% | +$5.04M | ﹤0.01% | 1627 |
|
|
2024
Q1 | $11.5M | Buy |
763,207
+700,203
| +1,111% | +$12.7M | ﹤0.01% | 1667 |
|
|
2023
Q4 | $1.36M | Sell |
63,004
-22,262
| -26% | -$411K | ﹤0.01% | 3066 |
|
|
2023
Q3 | $1.58M | Sell |
85,266
-23,790
| -22% | -$555K | ﹤0.01% | 2938 |
|
|
2023
Q2 | $2.76M | Sell |
109,056
-29,232
| -21% | -$736K | ﹤0.01% | 2713 |
|
|
2023
Q1 | $3.58M | Buy |
138,288
+79,539
| +135% | +$2.13M | ﹤0.01% | 2540 |
|
|
2022
Q4 | $1.53M | Sell |
58,749
-55,416
| -49% | -$1.49M | ﹤0.01% | 2923 |
|
|
2022
Q3 | $2.9M | Sell |
114,165
-34,162
| -23% | -$1.2M | ﹤0.01% | 2593 |
|
|
2022
Q2 | $4.88M | Sell |
148,327
-50,610
| -25% | -$2.15M | ﹤0.01% | 2294 |
|
|
2022
Q1 | $13.7M | Buy |
198,937
+15,383
| +8% | +$1.11M | ﹤0.01% | 1645 |
|
|
2021
Q4 | $16.4M | Buy |
183,554
+25,423
| +16% | +$3.04M | ﹤0.01% | 1573 |
|
|
2021
Q3 | $20M | Sell |
158,131
-505
| -0.3% | -$73.5K | 0.01% | 1264 |
|
|
2021
Q2 | $26.4M | Buy |
158,636
+14,360
| +10% | +$2.33M | 0.01% | 1152 |
|
|
2021
Q1 | $26.1M | Sell |
144,276
-65,989
| -31% | -$15.3M | 0.01% | 1123 |
|
|
2020
Q4 | $42M | Sell |
210,265
-26,198
| -11% | -$5.33M | 0.01% | 822 |
|
|
2020
Q3 | $51.8M | Sell |
236,463
-18,501
| -7% | -$3.92M | 0.02% | 627 |
|
|
2020
Q2 | $48.8M | Sell |
254,964
-333,596
| -57% | -$58.5M | 0.02% | 633 |
|
|
2020
Q1 | $91.4M | Buy |
588,560
+74,897
| +15% | +$8.71M | 0.05% | 357 |
|
|
2019
Q4 | $43M | Buy |
513,663
+15,177
| +3% | +$1.15M | 0.02% | 776 |
|
|
2019
Q3 | $33.8M | Sell |
498,486
-30,031
| -6% | -$1.98M | 0.02% | 830 |
|
|
2019
Q2 | $34.9M | Buy |
528,517
+10,123
| +2% | +$590K | 0.02% | 840 |
|
|
2019
Q1 | $28.7M | Buy |
518,394
+29,840
| +6% | +$1.82M | 0.01% | 923 |
|
|
2018
Q4 | $24.2M | Buy |
488,554
+180,012
| +58% | +$11M | 0.01% | 947 |
|
|
2018
Q3 | $26.6M | Buy |
308,542
+180,262
| +141% | +$12.8M | 0.01% | 1096 |
|
|
2018
Q2 | $7.43M | Buy |
128,280
+4,707
| +4% | +$230K | ﹤0.01% | 1965 |
|
|
2018
Q1 | $4.98M | Sell |
123,573
-56,935
| -32% | -$2.15M | ﹤0.01% | 2179 |
|
|
2017
Q4 | $6.29M | Sell |
180,508
-20,340
| -10% | -$675K | ﹤0.01% | 1966 |
|
|
2017
Q3 | $6.66M | Buy |
200,848
+109,373
| +120% | +$3.59M | ﹤0.01% | 1876 |
|
|
2017
Q2 | $3.17M | Sell |
91,475
-40,018
| -30% | -$1.17M | ﹤0.01% | 2374 |
|
|
2017
Q1 | $3.29M | Buy |
131,493
+73,231
| +126% | +$1.52M | ﹤0.01% | 2322 |
|
|
2016
Q4 | $962K | Buy |
58,262
+28,460
| +95% | +$483K | ﹤0.01% | 2990 |
|
|
2016
Q3 | $546K | Sell |
29,802
-62,595
| -68% | -$1.1M | ﹤0.01% | 3163 |
|
|
2016
Q2 | $1.48M | Buy |
92,397
+650
| +0.7% | +$7.58K | ﹤0.01% | 2690 |
|
|
2016
Q1 | $881K | Buy |
91,747
+7,130
| +8% | +$101K | ﹤0.01% | 2921 |
|
|
2015
Q4 | $1.52M | Buy |
84,617
+15,500
| +22% | +$286K | ﹤0.01% | 2747 |
|
|
2015
Q3 | $1.54M | Buy |
+69,117
| New | +$1.87M | ﹤0.01% | 2767 |
|
Other funds holding TDOC
VPM
VCM
VC
Ameriprise's TDOC Position: Q1 2026 in Review
Ameriprise increased its Teladoc Health (TDOC) stake by 20% in Q1 2026, buying an estimated $1.68M and bringing the position to 1,815,930 shares worth $9.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1932.
Ameriprise first reported a position in TDOC in Q3 2015 and has held it in 43 quarters since. The position peaked at $91.4M in Q1 2020. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.
- Ameriprise held 1,815,930 shares of Teladoc Health worth $9.9M as of Q1 2026.
- Ameriprise bought 298,759 Teladoc Health shares in Q1 2026, an estimated $1.68M.
- Teladoc Health made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #1932 holding.
- Ameriprise first reported a position in Teladoc Health in Q3 2015 and has held it in 43 quarters since.
- Ameriprise's Teladoc Health position peaked at $91.4M in Q1 2020.
- 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.